Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company is based in Dallas, Texas.
Stock data | 2024 | Change |
---|---|---|
Price | $1.22 | N/A |
Market Cap | $19.88M | N/A |
Shares Outstanding | 16.29M | N/A |
Employees | 83.00 | N/A |